A. Goldwich, S. S. Hahn, S. Schreiber, S. Meier, E. Kämpgen et al., Targeting HIV-1 Gag into the Defective Ribosomal Product Pathway Enhances MHC Class I Antigen Presentation and CD8+ T Cell Activation, The Journal of Immunology, vol.180, issue.1, pp.372-382, 2008.
DOI : 10.4049/jimmunol.180.1.372

P. J. Goulder and D. I. Watkins, Impact of MHC class I diversity on immune control of immunodeficiency virus replication, Nature Reviews Immunology, vol.80, issue.8, pp.619-63010, 1038.
DOI : 10.1038/nri2357

P. Gourzi, T. Leonova, and F. N. Papavasiliou, Viral induction of AID is independent of the interferon and the Toll-like receptor signaling pathways but requires NF-??B, The Journal of Experimental Medicine, vol.204, issue.2, pp.259-265, 2007.
DOI : 10.1084/jem.143.6.1453

G. Haché, M. T. Liddament, and R. S. Harris, The Retroviral Hypermutation Specificity of APOBEC3F and APOBEC3G Is Governed by the C-terminal DNA Cytosine Deaminase Domain, Journal of Biological Chemistry, vol.280, issue.12, pp.10920-10924, 2005.
DOI : 10.1074/jbc.M500382200

R. S. Harris, K. N. Bishop, A. M. Sheehy, H. M. Craig, S. K. Petersen-mahrt et al., DNA Deamination Mediates Innate Immunity to Retroviral Infection, Cell, vol.113, issue.6, pp.803-809, 2003.
DOI : 10.1016/S0092-8674(03)00423-9

M. Kamata, Y. Nagaoka, and I. S. Chen, Reassessing the Role of APOBEC3G in Human Immunodeficiency Virus Type 1 Infection of Quiescent CD4+ T-Cells, PLoS Pathogens, vol.79, issue.3, 2009.
DOI : 10.1371/journal.ppat.1000342.s002

T. L. Kieffer, P. Kwon, R. E. Nettles, Y. Han, S. C. Ray et al., G->A Hypermutation in Protease and Reverse Transcriptase Regions of Human Immunodeficiency Virus Type 1 Residing in Resting CD4+ T Cells In Vivo, Journal of Virology, vol.79, issue.3, pp.1975-1980, 1975.
DOI : 10.1128/JVI.79.3.1975-1980.2005

G. H. Kijak, L. M. Janini, S. Tovanabutra, E. Sanders-buell, M. A. Arroyo et al., Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells, Virology, vol.376, issue.1, pp.101-111, 2008.
DOI : 10.1016/j.virol.2008.03.017

F. A. Koning, E. N. Newman, E. Y. Kim, K. J. Kunstman, S. M. Wolinsky et al., Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets, Journal of Virology, vol.83, issue.18, pp.9474-94851001089, 1128.
DOI : 10.1128/JVI.01089-09

B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin et al., Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts, Nature, vol.424, issue.6944, pp.99-10310, 1038.
DOI : 10.1038/nature01709

R. Mariani, D. Chen, B. Schröfelbauer, F. Navarro, R. König et al., Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif, Cell, vol.114, issue.1, pp.21-31, 2003.
DOI : 10.1016/S0092-8674(03)00515-4

A. Moris, C. Nobile, F. Buseyne, F. Porrot, J. P. Abastado et al., DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation, Blood, vol.103, issue.7, pp.2648-2654, 2004.
DOI : 10.1182/blood-2003-07-2532
URL : https://hal.archives-ouvertes.fr/pasteur-01372698

E. N. Newman, R. K. Holmes, H. M. Craig, K. C. Klein, J. R. Lingappa et al., Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity, Current Biology, vol.15, issue.2, pp.166-170, 2005.
DOI : 10.1016/j.cub.2004.12.068

G. Peng, K. J. Lei, W. Jin, T. Greenwell-wild, and S. M. Wahl, Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti???HIV-1 activity, The Journal of Experimental Medicine, vol.13, issue.1, pp.41-46, 2006.
DOI : 10.1006/meth.2001.1262

D. A. Price, A. K. Sewell, T. Dong, R. Tan, P. J. Goulder et al., Antigen???specific release of ??-chemokines by anti-HIV-1 cytotoxic T lymphocytes, Current Biology, vol.8, issue.6, pp.355-358, 1998.
DOI : 10.1016/S0960-9822(98)70138-1

B. R. Rosenberg and F. N. Papavasiliou, Beyond SHM and CSR: AID and Related Cytidine Deaminases in the Host Response to Viral Infection, Adv. Immunol, vol.94, issue.06, pp.215-244, 2007.
DOI : 10.1016/S0065-2776(06)94007-3

A. Sáez-cirión, C. Lacabaratz, O. Lambotte, P. Versmisse, A. Urrutia et al., HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype, Agence Nationale de Recherches sur le Sida EP36 HIV Controllers Study Group Proc. Natl. Acad. Sci. USA, pp.6776-6781, 2007.
DOI : 10.1073/pnas.0611244104

M. H. Malim, and anti-A3G (National Institutes of Health reagent 9968) monoclonal antibodies were used. Statistical analysis Data were analyzed by a Wilcoxon rank-sum test with StatView statistics program (Abacus Concepts)

P. References-an, G. Bleiber, P. Duggal, G. Nelson, M. May et al., APOBEC3G genetic variants and their influence on the progression to AIDS, J. Virol, vol.78, pp.11070-11076, 2004.

V. Appay, D. C. Douek, and D. A. Price, CD8+ T cell efficacy in vaccination and disease, Nature Medicine, vol.205, issue.6, pp.623-628, 2008.
DOI : 10.1038/nm.f.1774

A. E. Armitage, A. Katzourakis, T. De-oliveira, J. J. Welch, R. Belshaw et al., Conserved Footprints of APOBEC3G on Hypermutated Human Immunodeficiency Virus Type 1 and Human Endogenous Retrovirus HERV-K(HML2) Sequences, Journal of Virology, vol.82, issue.17, pp.8743-87611000584, 1128.
DOI : 10.1128/JVI.00584-08

S. Cardinaud, A. Moris, M. Février, P. S. Rohrlich, L. Weiss et al., Identification of Cryptic MHC I???restricted Epitopes Encoded by HIV-1 Alternative Reading Frames, The Journal of Experimental Medicine, vol.157, issue.8, pp.1053-1063, 2004.
DOI : 10.1126/science.1089553
URL : https://hal.archives-ouvertes.fr/pasteur-01372661

Y. L. Chiu, V. B. Soros, J. F. Kreisberg, K. Stopak, W. Yonemoto et al., Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy, Nature. Immunity, vol.435, issue.27, pp.108-114406, 2005.

R. C. Desrosiers, J. D. Lifson, J. S. Gibbs, S. C. Czajak, A. Y. Howe et al., Identification of highly attenuated mutants of simian immunodeficiency virus, J. Virol, vol.72, pp.1431-1437, 1998.

C. Esnault, O. Heidmann, F. Delebecque, M. Dewannieux, D. Ribet et al., APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses, Nature, vol.16, issue.7024, pp.430-43310, 1038.
DOI : 10.1093/nar/30.11.e49
URL : https://hal.archives-ouvertes.fr/pasteur-01372656

N. C. Gaddis, E. Chertova, A. M. Sheehy, L. E. Henderson, and M. H. Malim, Comprehensive Investigation of the Molecular Defect in vif-Deficient Human Immunodeficiency Virus Type 1 Virions, Journal of Virology, vol.77, issue.10, pp.5810-5820, 2003.
DOI : 10.1128/JVI.77.10.5810-5820.2003

R. Goila-gaur and K. Strebel, HIV-1 Vif, APOBEC, and Intrinsic Immunity, Retrovirology, vol.5, issue.1, pp.51-61, 2008.
DOI : 10.1186/1742-4690-5-51

M. L. Santiago, M. Montano, R. Benitez, R. J. Messer, W. Yonemoto et al., Apobec3 Encodes Rfv3, a Gene Influencing Neutralizing Antibody Control of Retrovirus Infection, Science, vol.321, issue.5894, pp.1343-1346, 2008.
DOI : 10.1126/science.1161121

O. Schwartz, V. Maréchal, S. L. Gall, F. Lemonnier, and J. M. Heard, Endocytosis of major histocompatibility complex class I molecules is induced by the HIV???1 Nef protein, Nature Medicine, vol.12, issue.3, pp.338-342, 1996.
DOI : 10.1038/373123a0

M. Simm, M. Shahabuddin, W. Chao, J. S. Allan, and D. J. Volsky, Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes, J. Virol, vol.69, pp.4582-4586, 1995.

T. W. Tobery and R. F. Siliciano, Targeting of HIV-1 Antigens for Rapid Intracellular Degradation Enhances Cytotoxic T Lymphocyte (CTL) Recognition and the Induction of De Novo CTL Responses In Vivo After Immunization, The Journal of Experimental Medicine, vol.157, issue.5, pp.909-920, 1997.
DOI : 10.1093/infdis/170.5.1296

H. Tomiyama, M. Fujiwara, S. Oka, and M. Takiguchi, Cutting Edge: Epitope-Dependent Effect of Nef-Mediated HLA Class I Down-Regulation on Ability of HIV-1-Specific CTLs to Suppress HIV-1 Replication, The Journal of Immunology, vol.174, issue.1, pp.36-40, 2005.
DOI : 10.4049/jimmunol.174.1.36

J. P. Vartanian, A. Meyerhans, B. Asjö, and S. Wain-hobson, Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes, J. Virol, vol.65, pp.1779-1788, 1991.

J. P. Vartanian, D. Guétard, M. Henry, and S. Wain-hobson, Evidence for Editing of Human Papillomavirus DNA by APOBEC3 in Benign and Precancerous Lesions, Science, vol.320, issue.5873, pp.230-233, 2008.
DOI : 10.1126/science.1153201
URL : https://hal.archives-ouvertes.fr/pasteur-00363398

L. Wagner, O. O. Yang, E. A. Garcia-zepeda, Y. Ge, S. A. Kalams et al., Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans, Nature, vol.391, pp.908-911, 1998.

J. W. Yewdell and C. V. Nicchitta, The DRiP hypothesis decennial: support, controversy, refinement and extension, Trends in Immunology, vol.27, issue.8, pp.368-373, 2006.
DOI : 10.1016/j.it.2006.06.008

X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong et al., Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex, Science, vol.302, issue.5647, pp.1056-1060, 2003.
DOI : 10.1126/science.1089591

H. Zhang, R. J. Yang, C. Pomerantz, S. C. Zhang, L. Arunachalam et al., The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA, Nature, vol.424, issue.6944, pp.94-9810, 1038.
DOI : 10.1038/nature01707